Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

CSL and Arcturus Therapeutics have announced that Japan’s Ministry of Health, Labor and Welfare has granted approval for ...

Wells Fargo analyst Yanan Zhu maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) on September 13 and set a price ...

Ready to stargaze? Discover the brightest stars lighting up the night sky! Learn about these celestial wonders and their ...

Meanwhile Arcturus, a San Diego biotech working with messenger RNA (mRNA) therapies said it is working with Duke-NUS Medical School (Duke-NUS) to develop a coronavirus vaccine for Singapore.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant ...

周二，Canaccord Genuity维持对Arcturus Therapeutics (NASDAQ:ARCT)股票的买入评级和72.00美元的目标价，此举是在日本监管机构批准该公司更新的Kostaive JN.1配方用于18岁及以上成人之后。日本厚生劳动省的认可是该疫苗新毒株预期年度更新的一部分。 Arcturus Therapeutics此前于2023年11月获得了Kostaive的批准。

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...